| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.5M | -33.0% |
| SG&A Expense | $7.4M | -5.1% |
| Operating Income | -$22.9M | +25.9% |
| Net Income | -$22.5M | +19.8% |
| EPS (Basic) | -$0.65 | +21.7% |
| EPS (Diluted) | -$0.65 | +21.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | -82.9% |
| Current Assets | $3.6M | -82.4% |
| Total Assets | $4.6M | -78.8% |
| Current Liabilities | $11.4M | -10.1% |
| Stockholders' Equity | -$18.1M | -4399.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.8M | +16.5% |
| Capital Expenditures | $74K | -70.6% |
| Investing Cash Flow | -$74K | +70.6% |
| Financing Cash Flow | -$407K | -161.7% |
| Free Cash Flow | -$15.8M | +17.2% |